HomeScience

Category : Science

Transcenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ASCO 2024

Phase II results reveal median PFS of 12.6 months in patients with CLDN18.2 high or medium expression,including in patients with PD-L1 CPS<5.

ScienceMay 30, 2024

Omnicom Media Group Expands Its Partnership with Lumen, Further Advancing Attention-Based Planning Capabilities Across Its Regions

LONDON,May 24,2024-- Omnicom Media Group (OMG)the media services division of leading global marketing and corporate communications holding company Omnicom Group Inc (NYSE: OMC) is expanding its market

ScienceMay 30, 2024

VicOne achieves DEKRA ISO/SAE 21434 automotive cybersecurity certification, elevating integrated services to international level

TAIPEI,May 24,2024-- DEKRA,the automotive technology service provider recognized by EU government agencies,announced that it has successfully audited VicOne,a subsidiary of the cybersecurity giant Tr

ScienceMay 30, 2024

Visionary Holdings Inc. Announces Share Consolidation of Ordinary Shares

TORONTO,May 24,2024-- Visionary Holdings Inc. ("we",or the "Company") (NASDAQ: GV),a private education provider with technology of artificial intelligence and life science on the c

ScienceMay 30, 2024

XCMG Machinery Amplifies Presence in Latin America with More Tailor-Made Machines Launched

SAO PAULO,May 24,2024-- In a significant move to strengthen its foothold in the Latin American market,XCMG Machinery ("XCMG",SHE:000425) has ramped up its operations,marking the 50th anniver

ScienceMay 30, 2024
1 ... 262 263 264 265 266 267 268 ... 282
Your premier source for cutting-edge news in the realms of technology, artificial intelligence, energy, and more. Explore the future of tech with Arinstar! Stay informed, stay inspired!

Quick Search

Explore our curated content, stay informed about groundbreaking innovations, and journey into the future of science and tech.

© ArinstarTechnology

Privacy Policy